Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 1/20 | 0.40 |
| ▸ | RXRB | P28702 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | ERN1 | O75460 | 1/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.34 |
| ▸ | HMGCR | P04035 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.33 |
| ▸ | SRC | P12931 | 1/20 | 0.32 |
| ▸ | HTR1D | P28221 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | TYR | P14679 | 1/20 | 0.32 |
| ▸ | PGK1 | P00558 | 1/20 | 0.31 |
| ▸ | PGK2 | P07205 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL189788 | 0.86 | GABRA1 (0.46) | RXRARXRBCYP2A6POLBGABRA1 | |
| SCHEMBL14005550 | 0.86 | GABRA1 (0.40) | RXRARXRBCYP2A6POLBTSHR | |
| SCHEMBL15459309 | 0.83 | ERN1 (0.38) | RXRARXRBCYP2A6POLBERN1 | |
| SCHEMBL16348860 | 0.82 | CYP2A6 (0.42) | RXRARXRBCYP2A6EPHX2NR1H4 | |
| SCHEMBL2474610 | 0.81 | NFE2L2 (0.41) | CYP2A6ERN1PGK1PGK2MAPT | |
| SCHEMBL8011119 | 0.80 | GABBR2 (0.51) | RXRARXRBPOLBTSHRGABRA1 | |
| SCHEMBL8011123 | 0.80 | GABBR2 (0.51) | RXRARXRBPOLBTSHRGABRA1 | |
| SCHEMBL12944940 | 0.79 | CYP2A6 (0.33) | CYP2A6ERN1 | |
| SCHEMBL3201259 | 0.78 | GABRA1 (0.39) | RXRARXRBCYP2A6POLBGABRA1 | |
| SCHEMBL3264978 | 0.78 | GABRA1 (0.39) | RXRARXRBCYP2A6POLBGABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023019094-A1 | MONOACYLGLYCEROL LIPASE MODULATORS FOR USE IN AUTISM SPECTRUM DISORDERS | JANSSEN PHARMACEUTICA NV (BE) | 2023-02-16 | — | — | WO | disclosed |
| WO-2021160602-A1 | MONOACYLGLYCEROL LIPASE MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2021-08-19 | — | — | WO | disclosed |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2017-11-02 | — | — | US | disclosed |
| US-8716226-B2 | 3,5 phenyl-substituted beta amino acid derivatives as integrin antagonists | SAINT LOUIS UNIVERSITY (US) | 2014-05-06 | — | — | US | disclosed |
| US-20140051715-A1 | 3,5 Phenyl-Substituted Beta Amino Acid Derivatives as Integrin Antagonists | SAINT LOUIS UNIVERSITY (US) | 2014-02-20 | — | — | US | disclosed |
| US-6103688-A | TERT-BUTYL SUBSTITUTED INDAN DERIVATIVES | FIRMENICH SA (CH) | 2000-08-15 | — | — | US | disclosed |
| EP-0685444-B1 | Aromatic compounds and their use in perfumery | FIRMENICH & CIE (CH) | 2000-04-05 | — | — | EP | disclosed |
| US-5552379-A | FLORAL, FOR COSMETICS AND HOUSEHOLD ITEMS | FIRMENICH SA (CH) | 1996-09-03 | — | — | US | disclosed |
| EP-0685444-A1 | Aromatic compounds and their use in perfumery | FIRMENICH SA (CH) | 1995-12-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140051715-A1 | 3,5 Phenyl-Substituted Beta Amino Acid Derivatives as Integrin Antagonists | ITGB3, ITGB5, ITGA5 | RXRA 260/4885RXRB 200/4885CYP2A6 3386/4885 |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | HDGF, F11, F12 | RXRA 4327/4885RXRB 4355/4885CYP2A6 3508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.